First trimester screening program for preeclampsia and preterm delivery

First trimester screening test for preeclampsia and premature delivery

Immunohistochemical expression of NGF receptor (p-TRKA) in placental tissue of early-onset pre-eclampsia

Maternal plasma nerve growth factor at 11 to 13 weeks as a novel angiogenic marker of pre-eclampsia

Prediction of early pre-eclampsia by maternal characteristic, mean blood pressure and uterine artery Doppler

Predictive model of small-for-gestational newborn without pre-eclampsia at 11+0 – 13+6 weeks

Ultrasound examination of transient cerebral layers at 25 to 29 weeks’ gestation in severely FGR fetuses

The Dresden Registry: Maternal Morbidity in hypertensive disorders in pregnancies

The Dresden Registry: Fetal and neonatal outcome in hypertensive disorders in pregnancies

Fetal aortic isthmus: Doppler a predictive marker for IUGR fetuses

Amniotic fluid “sludge” as a risk factor for fetal growth restriction

Ratio of MCA/UA doppler velocimetry and perinatal outcome in pregnancies beyond term

Predictive value of mean arterial pressure in first trimester of pregnancy for risk of preeclampsia

Identification of Small-for-Gestational-Age fetuses at risk of adverse perinatal outcome

A study of the first and second trimester screening of preeclampsia and gestational hypertension

Prediction of small for gestational age neonates by fetal biometry and uterine artery Doppler at 19-22 weeks

First trimester prediction of fetal growth restriction in low risk pregnancies

Association of preeclampsia with maternal mean platelet volume

The effectiveness of the Barcelona fetal Medicine staging protocol in the management of IUGR

Screening for spontaneous preterm delivery and preeclampsia in the first trimester in twins

Characterization of immune patterns according to first trimester uterine artery Doppler

Vascular and tissue Doppler parameters for the detection of a high risk IUGR fetus

Uterine artery doppler pulsatility index at 11-14 weeks in ART pregnancies with egg-donation

The role of angiogenic factors for first trimester screening of fetal growth restriction

Placental growth factor in first trimester as a marker of adverse perinatal outcome

An inflamation marker in preeclampsia: neutrophil to lymphocyte ratio

A case of antenatal diagnosis of vasa praevia

Prevention of placental insufficiency by acetylsalicylic acid and low molecular weight heparin

Intake assay of angiogenic factors (sflt -1 / plgf) in the diagnosis and monitoring pre-eclampsia

Maternal characteristics, fetal biometry and fetal Doppler indices at 28 weeks’ gestation

Two cases of atypical presentation of severe PET in late pregnancy

Role of uterine artery Doppler in predicting an impaired placentation for thrombophilic women

Uterine artery Doppler in first and second trimesters as a “continuum” for LBW

Behavior sFlt-1 / PlGF ratio in twin pregnancies with and without preeclampsia compared with singleton pregnancies

Measurement of sFlt-1 / PlGF at 26 weeks for detection of early onset placental complications

Usefulness of BOLD MRI to assess fetal response to maternal hyperoxigenation in IUGR and normal fetuses

Prediction of preeclampsia by maternal ophthalmic artery doppler in the first and second trimester

Prediction of PE by brachial artery flow-mediated dilatation in the three trimesters

Fetal and placental tissue characterisation and the role of 3D and Doppler ultrasound in lung maturity

Cell-free fetal DNA as a predictor for preeclampsia

RCT: Comparison of 80 vs 160 mg of aspirin in pregnant women with previous history of preeclampsia

Number of episodes of reduced fetal movements at term: association with adverse perinatal outcome

Prediction of FGR by fetal biometry, uterine artery doppler and maternal demographic characteristics

Prediction of stillbirth by fetal biometry, uterine artery doppler and maternal demographic characteristics

Notch signaling pathway in late preterm and term placentas from pregnancies complicated by preeclampsia

PAPPA, PAPPA-2 and PLAC-1 placental expression in pregnancies with fetal growth restriction

The correlation of systemic inflammation markers in preeclampsia with cardiovascular risk

The role of some angiogenesis markers in preeclampsia management

Maternal serum oxidative stress markers and antioxidant enzyme levels in preeclampsia

Comparison of short-term perinatal outcome of pregnancies according to umbilical artery Dopplers

Placental ADAMTS-12 levels in the pathogenesis of preeclampsia and intrahepatic cholestasis of pregnancy

Usefulness of the uterine artery doppler flow velocimetry at 20 weeks

Doppler Modifications in Intrauterine Growth Restricted Fetuses: the DOMINO study

Reproducibility of transabdominal and transvaginal Doppler flow of uterine arteries during the first trimester

Cytokines as predictors in moderate and severe preeclampsia

High first-trimester maternal serum β-human chorionic gonadotrofin and adverse pregnancy outcome

Uterine artery pulsatility index in the first trimester in high risk population and adverse perinatal outcome

Preeclampsia in twin pregnancies: impact of chorionicity and number of liveborn infants

Impact of postnatal environmental enrichment in neurodevelopment in an animal model of IUGR

Determination of nitric oxide concentration in placental tissue with Electron Paramagnetic Resonance

Low first-trimester maternal serum pregnancy-associated plasma protein-A and adverse pregnancy outcome

Vascular biopsy of the placenta using VOCAL2 ultrasound software in the prediction of IUGR

Maternal serum copeptin, MR-proANP and procalcitonin levels at 11-13 weeks in the prediction of PE

The impact of aspirin dose on the prevention of preeclampsia and IUGR

Comparison of maternal and cord blood ischemia modified albumin levels in normal and PE pregnancies

Influence of neurotransmitters on cerebral vascular response to severe hypoxia in ovine fetuses

The risk of adverse pregnancy outcome in the setting of very low first trimester maternal PAPP-A levels

Placental T2* in normal pregnancy and in pregnancies complicated by fetal growth restriction

Comparing new and traditional definitions of fetal growth restriction: A retrospective analysis

Screening for late placental dysfunction with uterine artery Doppler at 28-34 weeks

Prediction model for pre-eclampsia using a combination of clinical biophysical and biochemical markers

Detection of antenatal viral infection in normal and preeclampsia complicated pregnancy

Effect of aspirin in the prevention of adverse pregnancy outcome in women

Prognostic value of admission plasma glucose in preeclampsia and HELLP syndrome

Early pregnancy maternal serum markers in the prediction of pre-eclampsia in twins

Comparison of PAPP-A levels, Doppler ultrasound measurements and pregnancy results

The expressions of B7-H1 and B7-H4 co-stimulatory molecules on dendritic cells in pre-eclampsia

The expressions of apoptosis markers are altered in CD4+CD25+FoxP3+ T regulatory lymphocytes in PE

Doppler velocimetry in preeclampsia and correlation with perinatal outcome

Risk stratification for the SGA infant: is green top guideline 31 deliverable in a busy hospital setting?

Fetal growth in spontaneous and IVF pregnancies: A prospective study

Longitudinal changes in uterine, umbilical and fetal MCA Doppler indices in late onset small fetuses

Circulating and myometrial markers of oxidative stress in pregnant women with fetal growth restriction

Prediction of SGA by third-trimester VEGF, sFlt1 and PlGF